Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Hemagglutinins, Viral (immunology) - Antigens, Viral (immunology)

Terms

32Hemagglutinins, Viral (immunology)
33Antigens, Viral (immunology)
20Hemagglutinins, Viral (genetics)

Associations

Freq.WeightAssociation
1212Antigens, Viral (immunology) - Hemagglutinins, Viral (immunology)
99Hemagglutinins, Viral (genetics) - Hemagglutinins, Viral (immunology)

Documents par ordre de pertinence
001F22 (1993) Y. Okuno [Japon] ; Y. Isegawa ; F. Sasao ; S. UedaA common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains
002129 (1990) G. N. Milligan [États-Unis] ; L. A. Morrison [États-Unis] ; J. Gorka ; V. L. Braciale [États-Unis] ; T. J. Braciale [États-Unis]The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen
002406 (1986) J. R. Bennink ; J. W. Yewdell ; G. L. Smith ; B. MossRecognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes
002450 (1985) Kuniaki Nerome [Japon] ; Yasuyuki Yoshioka [Japon] ; Shinichi Sakamoto [Japon] ; Hisao Yasuhara [Japon] ; Akira Oya [Japon]Characteristics of a swine recombinant influenza virus isolated in 1980: recombination between swine and the earliest Hong Kong (H3N2) viruses
000730 (2014) Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie]Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
001C00 (1996) H. Sagawa [Japon] ; A. Ohshima ; I. Kato ; Y. Okuno ; Y. IsegawaThe immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region.
001F27 (1992) S Q Li [États-Unis] ; J L Schulman ; T. Moran ; C. Bona ; P. PaleseInfluenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes.
002382 (1986) M. E. Andrew [Australie] ; B. E. H. Coupar [Australie] ; G. L. Ada [Australie] ; D. B. Boyle [Australie]Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants
002496 (1984) W. Graeme Laver [République populaire de Chine] ; Robert G. Webster [République populaire de Chine] ; C. M. Chu [République populaire de Chine]Summary of a Meeting on the Origin of Pandemic Influenza Viruses
002498 (1984) N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon]Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
002523 (1984) A. Yamada [États-Unis] ; L. E. Brown [États-Unis] ; R. G. Webster [États-Unis]Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: Influence of receptor specificity
002569 (1983) K. Nerome ; S. Sakamoto ; N. Yano ; T. Yamamoto ; S. Kobayashi ; R G Webster ; A. OyaAntigenic characteristics and genome composition of a naturally occurring recombinant influenza virus isolated from a pig in Japan.
002584 (1983) Clayton W. Naeve [États-Unis] ; Robert G. Webster [États-Unis] ; Virginia S. Hinshaw [États-Unis]Phenotypic variation in influenza virus reassortants with identical gene constellations
002955 (1979) W. M. Marine ; J. E. ThomasAntigenic memory to influenza A viruses in man determined by monovalent vaccines.
002D96 (????) F G Nagieva ; V G Nikulina ; E I Kuznetsova ; I B Koptiaeva ; N I Krasnova ; O N Ageeva ; O G Andzhaparidze[Preparation and properties of monoclonal antibodies to influenza virus A/Krasnodar/101/59 (H2N2)].
002E02 (????) I M Isma Lova ; E I Isaeva ; Z I Rovnova[Monoreceptor antibodies to the hemagglutinin antigenic determinants of influenza viruses H2N2 and their virus-neutralizing activity].
002E25 (????) E I Isaeva ; Z I Rovnova ; R Ia Podcherniaeva[Functional activity of monoclonal and monospecific antibodies in the interaction with antigenic sites of influenza virus hemagglutinin].
000042 (2019) M. Linster [Pays-Bas, Singapour] ; E. J. A. Schrauwen [Pays-Bas] ; S. Van Der Vliet [Pays-Bas] ; D. F. Burke [Royaume-Uni] ; P. Lexmond [Pays-Bas] ; T. M. Bestebroer [Pays-Bas] ; D. J. Smith [Royaume-Uni] ; S. Herfst [Pays-Bas] ; B. F. Koel [Pays-Bas] ; R. A. M. Fouchier [Pays-Bas]The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses
000653 (2014) Simon E. Hufton [Royaume-Uni] ; Paul Risley [Royaume-Uni] ; Christina R. Ball [Royaume-Uni] ; Diane Major [Royaume-Uni] ; Othmar G. Engelhardt [Royaume-Uni] ; Stephen Poole [Royaume-Uni]The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
000A27 (2012) Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo IcardiPhase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
000A50 (2012) Nicola Clementi ; Elena Criscuolo ; Matteo Castelli ; Nicasio Mancini ; Massimo Clementi ; Roberto BurioniInfluenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines
000E24 (2010) Ana Clara Monsalvo [Argentine] ; Juan P. Batalle [Argentine] ; M. Florencia Lopez [Argentine] ; Jens C. Krause [États-Unis] ; Jennifer Klemenc [États-Unis] ; Johanna Zea [Argentine, États-Unis] ; Bernardo Maskin [Argentine] ; Jimena Bugna [Argentine] ; Carlos Rubinstein [Argentine] ; Leandro Aguilar [Argentine] ; Liliana Dalurzo [Argentine] ; Romina Libster [Argentine] ; Vilma Savy [Argentine] ; Elsa Baumeister [Argentine] ; Liliana Aguilar [Argentine] ; Graciela Cabral [Argentine] ; Julia Font [Argentine] ; Liliana Solari [Argentine] ; Kevin P. Weller [États-Unis] ; Joyce Johnson [États-Unis] ; Marcela Echavarria [Argentine] ; Kathryn M. Edwards [États-Unis] ; James D. Chappell [États-Unis] ; James E. Crowe [États-Unis] ; John V. Williams [États-Unis] ; Guillermina A. Melendi [Argentine, États-Unis] ; Fernando P. Polack [Argentine, États-Unis]Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
000E59 (2010) Philippe R S. Lagacé-Wiens [Canada] ; Ethan Rubinstein ; Abba GumelInfluenza epidemiology--past, present, and future.
000E97 (2010) Seyyed Mahmoud Ebrahimi [Iran] ; Majid Tebianian ; Hadi Toghyani ; Arash Memarnejadian ; Hamid Reza AttaranCloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris.
001062 (2009) Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie]Pandemic Vaccine Preparedness—Have We Left Something Behind?
001125 (2009) Irina A. Leneva [Royaume-Uni] ; Rupert J. Russell ; Yury S. Boriskin ; Alan J. HayCharacteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol.
001250 (2008) Michelle Roti [États-Unis] ; Junbao Yang ; Deanna Berger ; Laurie Huston ; Eddie A. James ; William W. KwokHealthy human subjects have CD4+ T cells directed against H5N1 influenza virus.
001A96 (1998) A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
001B26 (1997) P. Zheng [États-Unis] ; Y. LiuCostimulation by B7 modulates specificity of cytotoxic T lymphocytes: a missing link that explains some bystander T cell activation.
001B99 (1996) W. Cao [États-Unis] ; B A Myers-Powell ; T J BracialeThe weak CD8+ CTL response to an influenza hemagglutinin epitope reflects limited T cell availability.
001D33 (1995) G. A. Tannock [Australie] ; J. R. Romanova [Russie] ; J. A. Paul [Australie]The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene
001E68 (1993) Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis]Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge
001F05 (1993) Judith R. Sch Ffr [Allemagne] ; Yoshihiro Kawaoka [Allemagne] ; William J. Bean [Allemagne] ; Jochen Süss [Allemagne] ; Dennis Senne [Allemagne] ; Robert G. Webster [Allemagne]Origin of the Pandemic 1957 H2 Influenza A Virus and the Persistence of Its Possible Progenitors in the Avian Reservoir
001F31 (1992) S. Dea [Canada] ; R. Bilodeau ; R. Sauvageau ; C. Montpetit ; G P MartineauAntigenic variant of swine influenza virus causing proliferative and necrotizing pneumonia in pigs.
002066 (1990) B V Migunova ; A Z Plusnin ; N A Petrov ; M I Rivkin ; E B Grinbaum ; L V Obuchova ; O K KuznetzovPrimary structure of the gene coding for the haemagglutinin of influenza virus A/Leningrad/385/80(H3N2): detection of a point mutation responsible for the antigenic drift.
002133 (1989) N P Arbatski ; A P Zheltova ; D V Iurtov ; V A Derevitskaia ; N K Kochetkov[Successive isolation of hemagglutinin and neuraminidase from influenza virus A/Kransnodar/101/59 (H2N2) using bromelain].
002283 (1987) E. Hamsíková ; H. Závadová ; M. Zaoral ; J. Jezek ; K. Bláha ; V. VonkaImmunogenicity of a synthetic peptide corresponding to a portion of the heavy chain of H3N2 influenza virus haemagglutinin.
002341 (1986) M H Snyder ; M L Clements ; R F Betts ; R. Dolin ; A J Buckler-White ; E L Tierney ; B R MurphyEvaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.
002343 (1986) H H Walls ; M W Harmon ; J J Slagle ; C. Stocksdale ; A P KendalCharacterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses.
002418 (1985) R. Pyhã LãAntibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.
002420 (1985) D. B. Golubev [Russie] ; G. I. Karpukhin [Russie] ; S. S. Galitarov [Russie] ; G. M. Denisov [Russie]Type A influenza (H2N2) viruses isolated in Leningrad in 1980
002482 (1984) G I Karpukhin ; T L Popova ; L S Karpova ; L M Tsybalova ; G M Denisov[Antigenic anachronism of the influenza A(H2N2) viruses in Leningrad in 1980. I. The epidemiological and serological characteristics of the influenzal infection caused by A/Leningrad/80 (H2N2) viruses].
002485 (1984) N K Mak ; C. Sweet ; G L Ada ; G A TannockThe sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses.
002489 (1984) Y Z Ghendon ; F I Polezhaev ; K V Lisovskaya ; T E Medvedeva ; G I Alexandrova ; A I KlimovRecombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants.
002541 (1984) K. Nerome [Japon] ; Y. Yoshioka [Japon] ; C. A. Torres [Japon] ; A. Oya [Japon] ; P. Bachmann [Allemagne] ; K. Ottis [Allemagne] ; R. G. Webster [États-Unis]Persistence of Q strain of H2N2 influenza virus in avian species: Antigenic, biological and genetic analysis of avian and human H2N2 viruses
002544 (1984) David R. Kaplan [États-Unis] ; Rogers Griffith [États-Unis] ; Vivian L. Braciale [États-Unis] ; Thomas J. Braciale [États-Unis]Influenza virus-specific human cytotoxic T cell clones: Heterogeneity in antigenic specificity and restriction by class II MHC products
002568 (1983) G L Smith ; B R Murphy ; B. MossConstruction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.
002641 (1982) B L Lu ; R G Webster ; V S HinshawFailure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions.
002669 (1982) H. F. Maassab [Géorgie (pays)] ; A. P. Kendal [Géorgie (pays)] ; G. D. Abrams [Géorgie (pays)] ; A. S. Monto [Géorgie (pays)]Evaluation of a Cold-Recombinant Influenza Virus Vaccine in Ferrets
002682 (1982) David C. Jackson [États-Unis] ; R. G. Webster [États-Unis]A topographic map of the enzyme active center and antigenic sites on the neuraminidase of influenza virus A/Tokyo/3/67 (H2N2)
002706 (1981) B R Murphy ; R M Chanock ; M L Clements ; W C Anthony ; A J Sear ; L A Cisneros ; M B Rennels ; E H Miller ; R E Black ; M M Levine ; R F Betts ; R G Douglas ; H F Maassab ; N J Cox ; A P KendalEvaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.
002754 (1981) H. Ertl [Australie] ; G. L. Ada [Australie]Roles of influenza virus infectivity and glycosylation of viral antigen for recognition of target cells by cytolytic T Lymphocytes
002784 (1980) G Q Liu ; X C Gong ; J M Zhu ; G F Ren ; R L Fan ; W Q RuanAntigenic relationship between H1 and H2 of influenza A virus.
002872 (1979) G L Ada ; K L YapThe measurement of haemagglutinin and matrix protein present on the surface of influenza virus infected P815 mastocytoma cells.
002901 (1979) Gillian M. Air [Australie]Nucleotide sequence coding for the “signal peptide” and N terminus of the hemagglutinin from an Asian (H2N2) strain of influenza virus
002A39 (1977) N J Dimmock ; A S Carver ; S I Kennedy ; M R Lee ; S. LuscombeInternal proteins of influenza virus: 35S-methionine peptide maps as genetic markers.
002D73 (????) A A Bakova ; V A Gusev ; I A Popov ; A I Gordienko ; Iu L. Krivorutchenko ; Iu S. Krivoshein[The use of the immunoperoxidase test with monoclonal antibodies for detecting influenza A viruses].
002D76 (????) F G Nagieva ; N I Krasnova ; V G Nikulina ; O G Andzhaparidze[The protective effect of hemagglutinin-specific monoclonal antibodies in experimental influenza infection].
002D79 (????) Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
002E01 (????) T E Medvedeva ; V K Kudriavtseva ; I V Zhikhareva ; V V Romashkina ; G I Aleksandrova ; A I Klimov[Mutations in the genes coding for hemagglutinin and neuraminidase in cold-adapted variants of the influenza virus A/Leningrad/134/57 (H2N2)].
002E05 (????) V M Zhdanov ; A N Slepushkin ; L M Kupriashina ; V V Ritova ; L V Feklisova[Level of antibodies to influenza viruses A and B in the blood sera of children under 13].
002E19 (????) I M Isma Lova[Highly active hyperimmune sera to H2N2 viruses devoid of nonspecific inhibitors].
002E31 (????) V F Lavrov ; V F Semenkov ; R A Alibaeva ; G M Nazarova ; L P Khodakova[Cytotoxic activity of normal killers and the lymphocytic proliferative response to specific viral antigens in influenza in mice].
002E36 (????) L M Garmashova ; F I Polezhaev ; G I Aleksandrova[Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021